semaglutide after breast cancer GLP-1 weight-loss drugs might help protect against cancer, study presented at ASCO meeting suggests Can You Take Ozempic with

Aquino, Universidad Austral, Argentina Reviewed by Moon Nyeo Park, Kyung Hee University, Republic of Korea Sohail Mumtaz, Gachon University, Republic of Korea Updates Copyright 2025 Zhao, Chen, Qiao, Wang, Ali, Li and Yin

Quick Answer: GLP-1 receptor agonists have not been definitively shown to directly cause clinically significant bone density loss, though the substantial weight reduction they produce may indirectly affect bone metabolism

Metabolic-rejuvenation and longevity research central to an emerging research framework that connects methylation tone, NAD availability and tissue-specific aging [1,3]

Patients should discuss breastfeeding considerations with their healthcare provider